Assessing transplant complication risk with total cell-free DNA
Abstract:
This invention relates to methods and compositions for assessing an amount of total cell-free DNA, such as from a transplant subject. The methods and composition provided herein can be used to determine risk of complications following transplantation, including infection, cardiac arrest, and death, in a subject.
Public/Granted literature
Information query
Patent Agency Ranking
0/0